99% High Quality Samaglutide Weight Loss Peptide

Long-acting GLP-1 receptor agonists, a prescription drug available for oral administration.

CAS: 910463-68-2
Purity: ≥99% 
Appearance: White lyophilized powder
Specifications: 2mg/bottle, 5mg/bottle, 10mg/bottle, 15mg/bottle, 20mg/bottle, 30mg/bottle
Molecular weight: ≈4113.6 Da
Half-life: ≈7 days (long-lasting and stable, once a week)

We’re currently running a popular 10% off promotion

Whatsapp:+852 98497616

Sincerely look forward to your inquiries.

1. Powerful weight loss： average weight loss of 10%–18%, suppresses appetite centers, delays gastric emptying, and reduces calorie intake; Reduces hunger and increases satiety, especially reducing visceral fat in the abdomen. Clinical studies show that a weekly dose of 2.4mg can reduce average weight loss by 15%–18%, far exceeding traditional weight loss regimens.
2. Excellent blood sugar reduction, with extremely low risk of hypoglycemia
Glucose dependence promotes insulin secretion and inhibits glucagon; It works when blood glucose is high, but not when blood glucose is normal; monotherapy carries a <1% risk of hypoglycemia. It significantly lowers glycated hemoglobin (HbA1c), making it suitable for people with type 2 diabetes combined with obesity.
3. Cardiovascular protection, reducing major adverse cardiovascular events
Lowers blood pressure, improves blood lipids (lowers triglycerides, raises HDL); Reduces the risk of heart attack, stroke, and cardiovascular death, FDA/EMA approved for cardiovascular protection indications.
4. Comprehensive metabolic improvement, suitable for metabolic syndrome
Improves insulin sensitivity, reduces liver fat deposits (improves fatty liver), and lowers inflammatory factors; Suitable for research on metabolic syndromes such as obesity, diabetes, hypertension, and hyperlipidemia.
5. Once a week, with high adherence and good tolerance
Long-acting mechanism enables subcutaneous once a week, maintaining stable plasma concentration; Gastrointestinal reactions (nausea, bloating) are mild and increase tolerance over time.

GLP-1 receptor activation: Precisely binds to GLP-1 receptors, mimics natural enteroreceptor, and regulates appetite, blood sugar, and metabolism.
Fatty acid chain modification: enhances albumin binding, resists enzymatic degradation, extends half-life to 7 days, and provides stable and lasting effects.
Multi-pathway synergy: central suppression of appetite, delayed gastric emptying, pancreatic regulation, reduction of liver gluconeogenesis, and promotion of adipolysis by adipose tissue.

✅ High-purity quality control: ≥99%, COA quality inspection report provided per batch.
✅ Long-lasting stability: Freeze-dried powder, long-term storage at -20°C, resistant to degradation, highly active.
✅ Comprehensive clinical validation: FDA/EMA approved drug ingredients, supported by massive Phase III clinical data.
✅ Complete specifications: Multiple sizes from 2mg to 30mg, suitable for different research and application scenarios.

Research on the mechanisms of weight management in obesity and overweight
Study on blood glucose control and complications in type 2 diabetes
Research on metabolic syndrome (hypertension, hyperlipidemia, fatty liver).
Research on reducing and protecting cardiovascular disease risks
Research on appetite regulation and eating behavior regulation
Research on non-alcoholic fatty liver disease (NAFLD) and liver metabolism